BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8917445)

  • 1. Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies.
    Williamson RA; Natalia D; Gee CK; Murphy G; Carr MD; Freedman RB
    Eur J Biochem; 1996 Oct; 241(2):476-83. PubMed ID: 8917445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
    Afzal AJ; Lightfoot DA
    Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of active recombinant TIMP-1 from Escherichia coli inclusion bodies and complex formation with the recombinant catalytic domain of PMNL-collagenase.
    Kleine T; Bartsch S; Bläser J; Schnierer S; Triebel S; Valentin M; Gote T; Tschesche H
    Biochemistry; 1993 Dec; 32(51):14125-31. PubMed ID: 8260495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refolding of TIMP-2 from Escherichia coli inclusion bodies.
    Williamson RA
    Methods Mol Biol; 2001; 151():257-65. PubMed ID: 11217304
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli.
    Upadhyay V; Singh A; Panda AK
    Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubilization and refolding of bacterial inclusion body proteins.
    Singh SM; Panda AK
    J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human TIMP-3 from Escherichia coli: synthesis, refolding, physico-chemical and functional insights.
    Negro A; Onisto M; Grassato L; Caenazzo C; Garbisa S
    Protein Eng; 1997 May; 10(5):593-9. PubMed ID: 9215578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refolding of TIMP-2 from Escherichia coli inclusion bodies.
    Williamson RA
    Methods Mol Biol; 2010; 622():111-21. PubMed ID: 20135279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
    Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
    J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
    Cao P; Mei JJ; Diao ZY; Zhang Sq
    Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies.
    Cardamone M; Puri NK; Brandon MR
    Biochemistry; 1995 May; 34(17):5773-94. PubMed ID: 7727438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodies.
    Raghava S; Barua B; Singh PK; Das M; Madan L; Bhattacharyya S; Bajaj K; Gopal B; Varadarajan R; Gupta MN
    Protein Sci; 2008 Nov; 17(11):1987-97. PubMed ID: 18780821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of recombinant ovine growth hormone with retention of native-like secondary structure and its refolding from the inclusion bodies of Escherichia coli.
    Khan RH; Rao KB; Eshwari AN; Totey SM; Panda AK
    Biotechnol Prog; 1998; 14(5):722-8. PubMed ID: 9758661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-assisted refolding of oligomeric small heat-shock protein Hsp26.
    Franzmann TM
    Int J Biol Macromol; 2006 Aug; 39(1-3):104-10. PubMed ID: 16626802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.
    Lee HJ; Im H
    Protein Expr Purif; 2003 Sep; 31(1):99-107. PubMed ID: 12963346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
    Razeghifard MR
    Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renaturation of recombinant ErmSF and its refolding behavior.
    Lee HJ; Jin HJ
    Mol Cells; 2003 Oct; 16(2):187-93. PubMed ID: 14651260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human retinol-binding protein refolding, native disulfide formation, and characterization.
    Xie Y; Lashuel HA; Miroy GJ; Dikler S; Kelly JW
    Protein Expr Purif; 1998 Oct; 14(1):31-7. PubMed ID: 9758748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-Step Preparation of Highly Pure, Soluble HIV Protease from Inclusion Bodies Recombinantly Expressed in Escherichia coli.
    Sherry D; Worth R; Sayed Y
    Curr Protoc Protein Sci; 2020 Jun; 100(1):e106. PubMed ID: 32339408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and refolding of a novel cancer/testis antigen BJ-HCC-2 expressed in the inclusion bodies of Escherichia coli.
    Yang XA; Dong XY; Li Y; Wang YD; Chen WF
    Protein Expr Purif; 2004 Feb; 33(2):332-8. PubMed ID: 14711522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.